OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
Meryem Grabski, Amy McAndrew, Will Lawn, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 152-162
Open Access | Times Cited: 100
Meryem Grabski, Amy McAndrew, Will Lawn, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 152-162
Open Access | Times Cited: 100
Showing 26-50 of 100 citing articles:
A unified model of ketamine’s dissociative and psychedelic properties
M. Marguilho, I. Figueiredo, Pedro Castro-Rodrigues
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 14-32
Open Access | Times Cited: 20
M. Marguilho, I. Figueiredo, Pedro Castro-Rodrigues
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 14-32
Open Access | Times Cited: 20
Substitution therapy for patients with alcohol dependence: Mechanisms of action and efficacy
Julien Guiraud, Rainer Spanagel, Wim van den Brink
International review of neurobiology (2024), pp. 187-239
Closed Access | Times Cited: 4
Julien Guiraud, Rainer Spanagel, Wim van den Brink
International review of neurobiology (2024), pp. 187-239
Closed Access | Times Cited: 4
Exploring the impact of music on response to ketamine/esketamine: A scoping review
Mina Kheirkhah, Allison C. Nugent, Alicia A. Livinski, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105693-105693
Closed Access | Times Cited: 4
Mina Kheirkhah, Allison C. Nugent, Alicia A. Livinski, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105693-105693
Closed Access | Times Cited: 4
The Role of Intravenous Anesthetics for Neuro: Protection or Toxicity?
Kaixin Wang, Yafeng Wang, Tianhao Zhang, et al.
Neuroscience Bulletin (2024)
Open Access | Times Cited: 4
Kaixin Wang, Yafeng Wang, Tianhao Zhang, et al.
Neuroscience Bulletin (2024)
Open Access | Times Cited: 4
Management of alcohol withdrawal syndromes in general hospital settings
Kristopher A. Kast, S. Alex Sidelnik, Shamim H. Nejad, et al.
BMJ (2025), pp. e080461-e080461
Closed Access
Kristopher A. Kast, S. Alex Sidelnik, Shamim H. Nejad, et al.
BMJ (2025), pp. e080461-e080461
Closed Access
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings
Claudio Agnorelli, Alessandra Cinti, G. Barillà, et al.
Molecular Psychiatry (2025)
Open Access
Claudio Agnorelli, Alessandra Cinti, G. Barillà, et al.
Molecular Psychiatry (2025)
Open Access
Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway
Xiaoming Ji, Zhimin Huang, Chenming Zhou, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Xiaoming Ji, Zhimin Huang, Chenming Zhou, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
Theodore Piper, Francesca Small, Sam P. Brown, et al.
Addiction (2025)
Open Access
Theodore Piper, Francesca Small, Sam P. Brown, et al.
Addiction (2025)
Open Access
Impact of psychedelics on craving in addiction: A systematic review
Sophie‐Athéna Chapron, Guilhem Bonazzi, Laura Di Lodovico, et al.
Journal of Psychopharmacology (2025)
Closed Access
Sophie‐Athéna Chapron, Guilhem Bonazzi, Laura Di Lodovico, et al.
Journal of Psychopharmacology (2025)
Closed Access
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)
Kathryn Fletcher, Nadine Ezard, Krista J. Siefried, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092504-e092504
Open Access
Kathryn Fletcher, Nadine Ezard, Krista J. Siefried, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092504-e092504
Open Access
Eficácia da cetamina e esketamina no tratamento da depressão: revisão das evidências e perspectivas futuras
RAPHAELA NOGUEIRA DUTRA, Mario Vitor Ferreira Nascimento, João Pedro Silva Gontijo, et al.
STUDIES IN HEALTH SCIENCES (2025) Vol. 6, Iss. 1, pp. e14206-e14206
Closed Access
RAPHAELA NOGUEIRA DUTRA, Mario Vitor Ferreira Nascimento, João Pedro Silva Gontijo, et al.
STUDIES IN HEALTH SCIENCES (2025) Vol. 6, Iss. 1, pp. e14206-e14206
Closed Access
Using cluster analysis to investigate consumption patterns in cases positive to ketamine: a national 7‐year study
Shyh-Yuh Wei, Chien‐Chou Su, Hsuan-Yun Hu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Shyh-Yuh Wei, Chien‐Chou Su, Hsuan-Yun Hu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Novel Insights into Addiction Management: A Meta-Analysis on Intervention for Relapse Prevention
Dana Cătălina Tabugan, Ana Cristina Bredicean, Teodora Anghel, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 619-619
Open Access
Dana Cătălina Tabugan, Ana Cristina Bredicean, Teodora Anghel, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 619-619
Open Access
PROPHYLACTIC KETAMINE: CURRENT KNOWLEDGE AND FUTURE DIRECTIONS
Astrid M. Cardona-Acosta, Lyonna F. Parise, Carlos A. Bolaños‐Guzmán, et al.
Biological Psychiatry (2025)
Closed Access
Astrid M. Cardona-Acosta, Lyonna F. Parise, Carlos A. Bolaños‐Guzmán, et al.
Biological Psychiatry (2025)
Closed Access
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization
Jennifer Jones
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Jennifer Jones
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Co-Occurring Bipolar and Substance Use Disorders: A Review of Impacts, Biopsychosocial Mechanisms, Assessment, and Treatment
Sarah H. Sperry, Elizabeth Lippard
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 2, pp. 173-182
Closed Access
Sarah H. Sperry, Elizabeth Lippard
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 2, pp. 173-182
Closed Access
Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice
Salam Hussain, Christopher Gale, Shanthi Sarma, et al.
Australian & New Zealand Journal of Psychiatry (2025)
Closed Access
Salam Hussain, Christopher Gale, Shanthi Sarma, et al.
Australian & New Zealand Journal of Psychiatry (2025)
Closed Access
The safety and efficacy of ketamine NMDA receptor blocker as a therapeutic intervention for PTSD review of a randomized clinical trial
Wisam Al Jumaili, Chintan Trivedi, Timothy Chao, et al.
Behavioural Brain Research (2022) Vol. 424, pp. 113804-113804
Closed Access | Times Cited: 16
Wisam Al Jumaili, Chintan Trivedi, Timothy Chao, et al.
Behavioural Brain Research (2022) Vol. 424, pp. 113804-113804
Closed Access | Times Cited: 16
Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study
Maud Rothärmel, Cherifa Benosman, Wissam El‐Hage, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 16
Maud Rothärmel, Cherifa Benosman, Wissam El‐Hage, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 16
Chronic exposure to (2 R,6 R)-hydroxynorketamine induces developmental neurotoxicity in hESC-derived cerebral organoids
Zhulin Du, Zhenle Zang, Jing Luo, et al.
Journal of Hazardous Materials (2023) Vol. 453, pp. 131379-131379
Closed Access | Times Cited: 10
Zhulin Du, Zhenle Zang, Jing Luo, et al.
Journal of Hazardous Materials (2023) Vol. 453, pp. 131379-131379
Closed Access | Times Cited: 10
Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies
Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 5, pp. 525-561
Closed Access | Times Cited: 3
Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 5, pp. 525-561
Closed Access | Times Cited: 3
The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)
Angela T.H. Kwan, Joshua D. Rosenblat, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 360, pp. 421-426
Closed Access | Times Cited: 3
Angela T.H. Kwan, Joshua D. Rosenblat, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 360, pp. 421-426
Closed Access | Times Cited: 3
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
E.M. Van Gent, J. Bryan, M Cleary, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 541-550
Open Access | Times Cited: 3
E.M. Van Gent, J. Bryan, M Cleary, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 541-550
Open Access | Times Cited: 3
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction
Ioanna A. Vamvakopoulou, David Nutt
European Addiction Research (2024), pp. 1-19
Open Access | Times Cited: 3
Ioanna A. Vamvakopoulou, David Nutt
European Addiction Research (2024), pp. 1-19
Open Access | Times Cited: 3
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates
Dale Terasaki, Ryan Loh, Anastasia Cornell, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 14
Dale Terasaki, Ryan Loh, Anastasia Cornell, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 14
